C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2002
12/19/2002	US20020194635 Transgenic bovine for use as animal model in the treatment of viral diseases
12/19/2002	US20020194634 Insect control system
12/19/2002	US20020194633 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
12/19/2002	US20020194632 Transgenic knockouts of BACE-1
12/19/2002	US20020194629 Treatment of Staphylococcus infections
12/19/2002	US20020194628 Gene-targeted animal model of apolipoprotein E4 domain interaction and uses thereof
12/19/2002	US20020194627 Expression vectors coding enzymatic polypeptide for us in gene therapy
12/19/2002	US20020194626 Knockout animals
12/19/2002	US20020194625 Transgenic animals expressing heparanase and its uses
12/19/2002	US20020193585 Novel human transporter proteins and polynucleotides encoding the same
12/19/2002	US20020193583 Novel human proteases and polynucleotides encoding the same
12/19/2002	US20020193582 69624, a novel human transporter family member and uses therefor
12/19/2002	US20020193580 Synthetic nucleotide sequences for use as tools in controlling genetic engineering
12/19/2002	US20020193579 Non-nucleotide containing enzymatic nucleic acid
12/19/2002	US20020193572 Generation of glycosylated antibody; obtain cell, incubate with vector expressing preferential antibody, transfected with a vector, propagate, express vector, recover antibody
12/19/2002	US20020193571 Wsx receptor agonist antibodies
12/19/2002	US20020193570 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
12/19/2002	US20020193561 P53 protein variants and therapeutic uses thereof
12/19/2002	US20020193361 For therapy of cancer and other conditions characterized by abnormal cellular proliferation
12/19/2002	US20020193338 Applying a biocompatible matrix containing the DNA molecule to a wound in the body, so that repair cells that migrate to the wound site infiltrate the matrix, acquire the DNA molecule, and express the gene product encoded by the DNA in vivo
12/19/2002	US20020193337 Gene therapy by secretory gland expression
12/19/2002	US20020193334 Reacting oligonucleotide, duplex DNA molecule, and cell-free enzyme mixture whereby gene-of-interest is modified at target site to form a modified gene of interest; introducing modified gene-of-interest into host organism; detecting expression
12/19/2002	US20020193333 For immunization for the therapy of diseases with or without combination chemotherapy
12/19/2002	US20020193331 Non-naturally occurring nucleic acid compositions, their use for the preparation of formulations useful for transfecting a nucleic acid into cells and applications
12/19/2002	US20020193330 Genetically engineered co-expression DNA vaccines, construction methods and uses thereof
12/19/2002	US20020193329 Useful as vaccines
12/19/2002	US20020193328 Use of gene product of adenovirus early region 4 ORF-6 to inhibit repair of double-strand breaks in DNA
12/19/2002	US20020193327 For therapy of eye disorders including retinitis pigmentosa, Stargardt's disease, diabetic retinopathies, retinal vascularization, or retinoblastoma
12/19/2002	US20020193317 Using smilagenin, prazerigenin, an astragaloside, tigogenin, ruscogenin, hecogenin and diosgenin in manufacture of medicament for therayp of condition characterised by deficiency in postsynaptic membrane-bound receptor number
12/19/2002	US20020193309 Contacting the sample or tissue with fibroblast growth factor 9 (FGF9) and allowing formation of receptor-ligand pairs; detecting presence of FGFR3-FGF9 pairs, a positive detection indicating presence of FGFR3 in the sample or tissue
12/19/2002	US20020193308 Recombinant protein and its use in therapy and diagnostics
12/19/2002	US20020193302 Use of FVIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
12/19/2002	US20020193300 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002	US20020193299 For use as pharmaceuticals, diagnostics, biosensors and bioreactors
12/19/2002	US20020193293 Low oxygen affinity mutant hemoglobins
12/19/2002	US20020193289 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
12/19/2002	US20020193288 Methods of treating hypertension and compositions for use therein
12/19/2002	US20020192840 Isolating preferential target particle in solution; obtain sample, incubate with binding particles, detet signal, recover particles
12/19/2002	US20020192827 Expression vector for use in prevention fungal infection
12/19/2002	US20020192826 Recombinant AAV vector-based transduction system and use of same
12/19/2002	US20020192825 Methods of use of viral vectors to deliver antigen to dendritic cells
12/19/2002	US20020192824 Viral vectors having chimeric envelope proteins containing the IgG-binding domain of protein A
12/19/2002	US20020192823 Expression vector for use as tool in gene therapy
12/19/2002	US20020192822 Herpes simplex virus ICP4 is an inhibitor of apoptosis
12/19/2002	US20020192820 Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/19/2002	US20020192819 Generation of preferential nucleotide sequences; obtain nucleotide sequences, incubate with vector, ligate, recover sequences
12/19/2002	US20020192813 Plant expression vectors
12/19/2002	US20020192802 Replication competent herpes virus strains
12/19/2002	US20020192801 Human uridine diphosphate galactose-4-epimerase
12/19/2002	US20020192800 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of thrombosis, emphysema and liver disorders
12/19/2002	US20020192799 Polypeptides for use in the treatment and prevention of infections
12/19/2002	US20020192796 Anti-sigma28 factors in Helicobacter pylori, Campylobacter jejuni and Pseudomonas aeruginosa and applications thereof
12/19/2002	US20020192795 Cathepsin for use in the treatment of bone and cancer disorders
12/19/2002	US20020192793 Isolation of the biosynthesis genes for pseudo-oligosaccharides from Streptomyces glaucescens GLA.O, and their use
12/19/2002	US20020192791 Genration of phytase for use in animal feeds; obtain genetically engineered yeast, express vector, recover phytase
12/19/2002	US20020192789 Novel enterokinase cleavage sequences
12/19/2002	US20020192788 Preferential kinase for use in generation of nucleoside monophosphates
12/19/2002	US20020192787 Polypeptide for use in the diagnosis, treatment, and prevention of cancer and developmental defects
12/19/2002	US20020192785 For use in therapeutics, diagnostics, and as research tools
12/19/2002	US20020192783 (R)-2-octanol dehydrogenases, methods for producing the enzymes, DNA encoding the enzymes, and methods for producing alcohols using the enzymes
12/19/2002	US20020192782 Enzymatic polypeptide for use in the generation of pharmeceuticals
12/19/2002	US20020192781 Desaturase antigen of mycobacterium tuberculosis
12/19/2002	US20020192777 Polypeptide for use in the treatment of inflammatory defects
12/19/2002	US20020192776 Nucleotide sequences coding polypeptide for use as insecticide
12/19/2002	US20020192772 Generation of glutamic acid by fermentation; obtain microorganism, incubate in nutrient broths, recover glutamic acid
12/19/2002	US20020192771 Beta -fructofuranosidase and its gene, method of isolating beta -fructofuranosidase gene, system for producing beta -fructofuranosidase, and beta -fructofuranosidase variant
12/19/2002	US20020192769 Polymerase chain reaction of DNA of which base sequence is completely unidentified
12/19/2002	US20020192767 Biosynthesis of polyketide synthase substrates
12/19/2002	US20020192760 Nucleotide sequences coding membrane protein for use the diagnosis and treatment of asthma, parkinson's, heart defects, hypotension, urogenital disorders
12/19/2002	US20020192758 C3b/C4b complement receptor-like molecules and uses thereof
12/19/2002	US20020192757 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
12/19/2002	US20020192756 Multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides
12/19/2002	US20020192755 Generation of preferential protein in genetically engineered cell; obtain genetically engineeredd cell, express vector, recover protein
12/19/2002	US20020192754 Generation of preferential serine proteases; obtain genetically engineered prokaryotic cell, transform with gene expressing serine proteases, recover serine proteases
12/19/2002	US20020192753 Method of making proteins in transformed yeast cells
12/19/2002	US20020192750 Polypeptide for use in the treatment and diagnosis of solid tumors, rheumatoid arthritis, vision defects and atherosclerosis
12/19/2002	US20020192749 Human polynucleotides, polypeptides, and antibodies
12/19/2002	US20020192744 Useful in the nutrition of patients suffering from phenylketonuria
12/19/2002	US20020192743 Method for the expression of proteins in in vitro translation systems with coexpression of folding helper proteins
12/19/2002	US20020192737 Detecting modulators of oxidoreductases; obtain sample, incubate with modulator, detect signal, monitor adjustment in enzyme activity
12/19/2002	US20020192729 Apoptosis protein for use in the diagnosis and treatment of cell proliferative disorders
12/19/2002	US20020192721 Modular molecular clasps and uses thereof
12/19/2002	US20020192709 Detection of modulators of receptor binding activity; obtain sample containing receptor, incubate with modulator, monitor adjustment of binding activity of receptor
12/19/2002	US20020192705 Clonal expansion of T cells of unknown specificity and identification of ligand recognized by the clonally expanded T cells
12/19/2002	US20020192700 Classification of cells; obtain cells, incubate with preferential nucleotide sequences, detect hybridzation, classify cells
12/19/2002	US20020192699 Genes and gene expression products that are differentially regulated in prostate cancer
12/19/2002	US20020192698 Detection of cancerous mammay gland cells in sample; obtain cells, extract nucleotide sequences, incubate with probe, detect signal, presence of signal indicates cancer
12/19/2002	US20020192695 Detection of modulator of tumor suppressor activity; obtain sample of polypeptide, incubate with modulator, monitor adjustment in polypeptide activity
12/19/2002	US20020192694 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of depression, anxiety, nervous system, obesity, high blood pressure and connective tissue disorders
12/19/2002	US20020192691 Analysis of preferential nucleotide sequence; obtain solid support, generate nucleotide sequences solid support, incubate with sample, expose to probe, detect hybridization signal
12/19/2002	US20020192689 Detection of preferential nucleotidse sequences; obtain sample, incubate with probe, detect signal, recover nucleotide sequences
12/19/2002	US20020192688 Imaging nucleic acid delivery
12/19/2002	US20020192686 Recovery of cells expressing preferential phenotypes; obtain cells, store phenotypic data, monitor phenotypic adjustments in cells, recover and classify phenotypes of interest
12/19/2002	US20020192685 Method for target site selection and discovery
12/19/2002	US20020192682 Polynucleotides and polypeptides of the IFNalpha-2 gene
12/19/2002	US20020192681 Detection of parasite in sample; obtain sample, isolate nucleotide sequences from dendritic cells, determine gene expression, presence of preferential gene indicates infections
12/19/2002	US20020192677 Amplification of preferential nucleotide sequences; obtain nucleic acid sample, incubate with primers and polymerase, amplify, recover nucleotide sequences
12/19/2002	US20020192675 Detection of nucleotide sequences coding polypeptide associated with controlling gene expression; obtain cells, transform with nucleotide sequences coding regulatory polypeptides, monitor adjustment in preferential gene
12/19/2002	US20020192674 Nucleotide sequences coding protein for use in the fermentation of amino acids
12/19/2002	US20020192673 Solid support for use in the generation of translated nucleic acid sequences

1 ... 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 2650 2651 2652 2653 2654 ... 4023